Lecture 7: Endocrine Pancreas Flashcards

1
Q

What cells are found in the Islets of Langerhans; where are they located and what do they secrete?

A

β cells: secrete insulin and C-peptide; located in central core

α cells: secrete glucagon; located near the periphery

D cells: secrete somatostatin, interspersed between α and β cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do the cells of the islets of Langerhans communicate w/ eachother?

A

Gap junctions:

  • Rapid cell-to-cell communication
  • β-β; α-α; and α-β
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the blood supply like to the Islets of Langerhans; how does this relate to the paracrine mechanism of the hormones within the endocrine pancreas?

A
  • Receive 10% of the total pancreatic blood flow
  • Venous blood from one cells type bathes the other cells types
  • Venous blood from the β carries insulin to the α and D cells
  • Blood flows first to center (for insulin), then:
  • Flows through periphery acting on α-cells inhibiting glucagon release.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the main stimulatory factor for insulin secretion?

A

Glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the components of preproinsulin vs. proinsulin vs. insulin?

A

Preproinsulin: signal peptide, A and B chains and C peptide

Proinsulin: no signal peptide, C peptide still attached

Insulin: is packaged w/ C peptide, but only consists of the A and B chains whilst inside secretory vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is C peptide significant?

A
  • Is released in equimolar amounts into the blood w/ insulin and excreted unchanged in urine
  • Can be used as a long-term marker of endogenous insulin secretion, specifically endogenous B cell function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are Sulfonylurea drugs (i.e., tolbutamide, glyburide) and what are they used for?

A

Promote the closing of the ATP-dependent K+ (inward-rectifier K+ channel); increasing insulin secretion; used in the treatment of Type II DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the 6 steps upon glucose binding pancreatic B-cell to insulin release

A

1) Glucose enters cell via GLUT-2
2) Phosphorylated by Glucokinase
3) G-6-P is oxidized promoting ATP generation
4) ATP closes the ‘inward-rectifying’ K+ channel; membrane depolarization
5) Activation of voltage-gated Ca2+ channels; Ca2+ enters cell
6) Vesicles of insulin mobilized to plasma membran and exocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the proportionality of insulin secretion in relation to blood glucose?

A

Insulin secretion is basically proportional to plasma glucose changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does biphasic secretion of insulin refer to; which phase is lost first in diabetic patients?

A

First phase: rapid and transient release

Second phase: delayed/longer chronic phase of release

*First phase is the first thing to dissapear in diabetic individuals*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the other modulators of insulin secretion?

A
  • GI peptides, glucagon, somatostatin, and ACh
  • Different intracellular pathways
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is GLUT-4 translocated to the plasma membrane; what else stimulates this process and why is this significant?

A
  • Activation of AMP-kinase (AMPK) upon insulin binding its receptor
  • Muscle contractions stimulate this process, highlighting the importance of exercise in the management of insulin resistance and/or diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is glucose taken up by peripheal cells?

A

Facilitated diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Insulin is important for glucose uptake into what tissues?

A

Adipose tissue, resting skeletal muscle, and liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the major effects of insulin on skeleal muscle?

A
  • Increased glucose uptake and GLUT 4 transporter
  • Activates glycogen synthase = increased glycogen synthesis
  • Increased glycolysis and CHO oxidation (hexokinase, PFK, PDH)
  • Increased protein synthesis and decreased breakdown
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the major effects of insulin on the liver?

A
  • Promotes glycogen synthesis (glucokinase and glycogen synthase)
  • Increased glycolysis and CHO oxidation
  • Decreases gluconeogenesis
  • Increases hexose monophosphate shunt
  • Increase pyruvate oxidation
  • Increase lipid storage and decrease lipid oxidation
  • Increase protein synthesis and decrease breakdown
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are insulins actions on Adipose Tissue?

A
  • Increases glucose uptake (GLUT 4 trasnlocation)
  • Increases glycolysis (increased production of α-glycerol phosphate for esterification and lipogenesis)
  • Decreased lipolysis (inhibits HSL)
  • Promotes uptake of FA’s (LPL activity/synthesis), favoring the formation of TAG’s
18
Q

What is the effect of insulin on the blood levels of K+, glucose, FA’s, ketoacids, and AA’s?

A

Decreases them all!

19
Q

What is one of the common treatments for hyperkalemia?

A

The administration of some insulin w/ small amount of glucose.

20
Q

What are some of the stimulatory factors for the secretion of insulin?

A
  • Increased [Glucose]
  • Increased [AA]
  • Increased [FA] and [Ketoacid]
  • Glucagon
  • GIP (glucose-dependent insulinotropic peptide)
  • Vagal stimulation; ACh
  • K+
  • Sulfonylurea rugs
  • Obesity
21
Q

What are some of the inhibitory factors for the secretion of insulin?

A
  • Decreased blood glucose
  • Fasting
  • Exercise
  • Somatostatin
  • α-adrenergic agonists
  • Diazoxide (K+ channel activator)
22
Q

How is the signal for insulin shut down?

A

Lysosomes will internalize the receptor from the plasma membrane, shutting down the signal

23
Q

What is Type I DM; symptoms seen when and what metabolic problems occur?

A
  • Inadequate insulin secretion
  • Destruction of β cell, often the result of autoimmune disease
  • Symptoms do not become evident until > 80% of β cells are destroyed
  • Increased blood glucose, fatty acids, ketoacids, amino acids, increased conversion of fatty acids to ketoacids
  • Results in diabetic ketoacidosis (DKA): metabolic acidosis
24
Q

How does hyperkalemia develop in Type I DM patients; what are the total body K+ levels like?

A
  • Shift of K+ out of the cell
  • Intracellular concentration is low
  • Lack of insulin effect on Na+/K+ ATPase
  • Even though plasma levels may be able normal, total body K+ is usually below normal due to the polyuria and dehydration
25
How does Osmotic diuresis result from Type I DM?
- Increased blood [glucose] results in **increased filtered load** of glucose, exceeding reabsorptive capacity of the **proximal tubule** - Water and electrolyte **reabsorption** is also **prevented** - Polyuria: **increases excretion of Na+ and K+** even though urine concentration of electrolytes is low - Thirst (polydipsia)
26
What is the goal w/ insulin replacement treatment for Type I DM?
To recreat normal physiology (basal and bolus insulin)
27
What is Type 2 DM
- Insulin resistance - Progressive **exhaustion** of β-cells due to enviornmental factors, including a sedentary lifestyle, malnutrition, or obestiy - Patients ARE able to make insulin, but NOT enough to overcome insulin resistance
28
What is the progression of insulin resistance seen in Type II DM?
Reactive hyperinsulinemia (at first) followed by relative hypoinsulinemia as β-cells begin to fail
29
What are 3 causes of obestity-induced insulin resistance?
- Decreased GLUT-4 uptake of glucose in response to insulin - Decreased ability of insulin to repress hepatic glucose production - Inability of insulin to repress adipose tissue **FA** uptake (**via LPL**) and **lipolysis (via HSL)**
30
What are some more of the pathophysiologies seen w/ Type II DM; is ketoacidosis an issue?
- Post-receptor signaling, which ultimately results in decrease of glucose transportr number - Increased hepatic glucose production - Hyperglucagonemia - NOT as prone to ketoacidosis as type I, but may still occur - In non-obese pt's, Type II DM can occur due to decreases in insulin release by the pancreas; varying degrees of insulin resistance can also occur
31
What are some of the contributing factors to activation of stress kinases and disruption of insulin signaling?
- Fatty acyl carnitines - Ceramides - DAGs **\*Intermediates produced by mitochondrial overload that activate pathways which inhibit insulin signaling**
32
What are some of the TX for Type II DM?
- Caloric restriction, exercise, weight reduction - Insulin secretagogues - Slow absorption of CHO's - Insulin sensitizers (i.e., **Metformin**) - Bariatric surgery good option for BMI \>40/obese pre-diabetic
33
What is the incretin effect?
- You get a much more robust insulin response when intaking glucose orally vs. an IV injection of glucose - Due to the **potent incretin hormones GLP-1 and GIP**
34
What are the incretin hormones; secreted when; half-life; and function?
- Intestine derived hormones: **GLP-1 and GIP** - Short half-life - Secreted in response to GI glucose and fat - **Stimulate insulin** secretion (glucose dependent) - **Inhibit glucagon** secretion - Slow gastric emptying
35
What type of receptor do the incretin hormones act on and what are the downstream signaling molecules?
GPCR; Gs pathway ---\> increased adenylyl cyclase ---\> increased cAMP-----\> Increased PKA ----\> insulin secretion
36
What happens to the incretin effect in Type II DM?
- Reduced Incretin effect
37
What are some of the associated conditions commonly seen w/ Type I DM?
- Autoimmune thyroid disease - Celiac Disease - Addison's disease
38
Glucagon is a member of a family of peptide that includes what other hormones?
Secretin and GIP
39
What is the major stimulatory factor of glucagon secretion and what are some other sitmulatory factors?
Major = **decreased** blood [glucose] Other: - Increased AA's (**arginine and alanine**) - Fasting - CCK - β-adrenergic agonists - ACh
40
What inhibits glucagon?
- Insulin **inhibits** the synthesis and secretin of glucagon - Somatostatin - Increased [FA] and [Ketoacid]
41
What are the major actions of glucagon on the liver?
- Increases blood [glucose] - Increased glycogenolysis and inhibits glycogen formation - Increased gluconeogenesis by decreasing the production of fructose-2,6-bisphosphate - Substrates are directed toward glucose formation
42
What are the effects of glucagon on adipose tissue?
- Increases **lipolysis** and inhibits FA synthesis, which shunts substrates towards **gluconeogenesis** - **Ketoacids are produced** from FA's, but not to the extent of a diabetic